Medical Developments International Limited

Medical Developments International (MDI) is an Australian-based specialized healthcare company focused on emergency medical solutions. The company operates through two primary segments: Pain Management and Respiratory. Its flagship product is Penthrox (methoxyflurane), a fast-acting, non-opioid analgesic inhaler used for trauma and emergency pain relief in hospitals, ambulance services, and for short surgical procedures. Additionally, MDI manufactures and distributes a range of respiratory devices for asthma and COPD management, including spacers, peak flow meters, and nebulizers.